Worse, growth factors could further enhance the drug resistance in subpopulations of GBM cells harboring amplifications of EGFR and PDGFR-α genes (Szerlip et al., 2012; Wilson et al., 2012). The gene discussed is EGFR; the disease is glioblastoma.